Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Where someone lives can affect their health. For breast cancer survivors, their neighborhood can influence their recovery ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

In a groundbreaking development, First Ascent Biomedical unveils a compelling narrative of resilience and innovation through ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

Hundreds of cancer patients spent more than 62 days waiting between referral and their treatment at NUH recent figures show.

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Biocon Biologics to launch Trastuzumab, Nivolumab, Pembrolizumab biosimilars for cancer. Expanding oncology portfolio.

King Charles is heading into 2026 facing a convergence of personal resilience tests and institutional decisions aides tell ...